
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Research progress of astragaloside IV in the treatment of atopic diseases
Shencun Yu, Peng Wen-dong, Fanghong Qiu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113989-113989
Open Access | Times Cited: 11
Shencun Yu, Peng Wen-dong, Fanghong Qiu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113989-113989
Open Access | Times Cited: 11
Showing 11 citing articles:
Mechanisms of ferroptosis regulating oxidative stress and energy metabolism in myocardial ischemia-reperfusion injury and a novel perspective of natural plant active ingredients for its treatment
Tianqing Zhang, Wenxu Deng, Ying Deng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 114706-114706
Open Access | Times Cited: 30
Tianqing Zhang, Wenxu Deng, Ying Deng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 114706-114706
Open Access | Times Cited: 30
Astragaloside/PVP/PLA nanofiber functional dressing prepared by coaxial electrostatic spinning technology for promoting diabetic wound healing
H. Wang, Lihong V. Wang, Zemei Liu, et al.
European Polymer Journal (2024) Vol. 210, pp. 112950-112950
Closed Access | Times Cited: 10
H. Wang, Lihong V. Wang, Zemei Liu, et al.
European Polymer Journal (2024) Vol. 210, pp. 112950-112950
Closed Access | Times Cited: 10
Modulation of the vitamin D receptor by traditional Chinese medicines and bioactive compounds: potential therapeutic applications in VDR-dependent diseases
Minghe Yao, Patrick Kwabena Oduro, Ayomide M. Akintibu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Minghe Yao, Patrick Kwabena Oduro, Ayomide M. Akintibu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
MRI evaluation of neuroprotective effects of Astragaloside Ⅳ on rotenone-induced late-stage Parkinson’s disease mice
Miaomiao Liu, Jing Wang, Rui Wang, et al.
Neuroscience (2025) Vol. 568, pp. 195-201
Closed Access
Miaomiao Liu, Jing Wang, Rui Wang, et al.
Neuroscience (2025) Vol. 568, pp. 195-201
Closed Access
Safety and onset time of modified Yupingfeng nasal spray versus mometasone furoate nasal spray on house dust mites-induced moderate to severe allergic rhinitis: a prospective, multicenter, randomized, open-label, parallel-group clinical trial
Huan Wang, Ting Liu, Chao Liao, et al.
Journal of Ethnopharmacology (2025), pp. 119574-119574
Closed Access
Huan Wang, Ting Liu, Chao Liao, et al.
Journal of Ethnopharmacology (2025), pp. 119574-119574
Closed Access
Traditional Chinese Medicine in the Treatment of Chronic Atrophic Gastritis, Precancerous Lesions and Gastric Cancer
Yuxi Liu, Tingting Huang, Lu Wang, et al.
Journal of Ethnopharmacology (2024) Vol. 337, pp. 118812-118812
Open Access | Times Cited: 4
Yuxi Liu, Tingting Huang, Lu Wang, et al.
Journal of Ethnopharmacology (2024) Vol. 337, pp. 118812-118812
Open Access | Times Cited: 4
Astragalus membranaceus, Nigella sativa, and Perilla frutescens as Immunomodulators—Molecular Mechanisms and Clinical Effectiveness in Allergic Diseases
Maja Bival Štefan
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 9016-9032
Open Access | Times Cited: 2
Maja Bival Štefan
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 9016-9032
Open Access | Times Cited: 2
Astragaloside IV Attenuates Programmed Death-Ligand 1-Mediated Immunosuppression during Liver Cancer Development via the miR-135b-5p/CNDP1 Axis
Yang Ma, Yan Li, Taotao Wu, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5048-5048
Open Access | Times Cited: 7
Yang Ma, Yan Li, Taotao Wu, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5048-5048
Open Access | Times Cited: 7
Recent pharmacological advances in the treatment of cardiovascular events with Astragaloside IV
Zehui Xu, Houle Zhou, Yihan Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115752-115752
Open Access | Times Cited: 7
Zehui Xu, Houle Zhou, Yihan Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115752-115752
Open Access | Times Cited: 7
Astragaloside IV Inhibits Rotenone-Induced α-syn Presentation and the CD4 T-Cell Immune Response
Mengdi Wang, Fengjiao Sun, Xiaofeng Han, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 1, pp. 252-265
Open Access | Times Cited: 3
Mengdi Wang, Fengjiao Sun, Xiaofeng Han, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 1, pp. 252-265
Open Access | Times Cited: 3
Anti-inflammatory and DNA Repair Effects of Astragaloside IV on PC12 Cells Damaged by Lipopolysaccharide
Xiaojun Liu, Li‐Hua Shao, Xi Chen, et al.
Current Medical Science (2024) Vol. 44, Iss. 4, pp. 854-863
Closed Access
Xiaojun Liu, Li‐Hua Shao, Xi Chen, et al.
Current Medical Science (2024) Vol. 44, Iss. 4, pp. 854-863
Closed Access